findmyKOL
Clinical trialNCT03311269TerminatedPhase 2Interventional

A Study Evaluating ClariVein With a Sclerosing Agent for the Treatment of Venous Insufficiency

SponsorVascular Insights, LLCEnrollment19Venous Insufficiency
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

VICARES is a prospective randomized, controlled, multi-center, double blind study treating venous insufficiency associated with incompetent saphenous veins with 1% and 3% Sodium Tetradecyl Sulfate (STS) solution utilizing the ClariVein system.
clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

5 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • the Vascular Experts

    Darien, Connecticut, United States

  • Capitol Vein and Laser Centers

    Frederick, Maryland, United States

  • Southeastern Surgical Associates

    Hyannis, Massachusetts, United States

  • Englegwood Hospital and Medical Center

    Englewood, New Jersey, United States

  • Lake Washington Vascular, Pllc

    Bellevue, Washington, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

Sodium Tetradecyl Sulfate 1% InjectionSodium Tetradecyl Sulfate 3% Injection
Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
22 Sept 2017
Primary completion
15 May 2018
Completion
27 Mar 2020
Last update posted
2 Mar 2022
Registered enrollment
19
Registry id
NCT03311269
clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.